🇺🇸 FDA
Patent

US 9669016

Antiparasitic effect of Bis[3,5-Bis(Benzylidene)-4-Oxo-1-Piperidinyl]amide Derivatives

granted A61KA61K31/13A61K31/132

Quick answer

US patent 9669016 (Antiparasitic effect of Bis[3,5-Bis(Benzylidene)-4-Oxo-1-Piperidinyl]amide Derivatives) held by The Board of Regents of the University of Texas System expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/13, A61K31/132, A61K31/4545, A61K45/06